The platform provides researchers with an instantaneous view of study performance. Credit: Mdisk / Shutterstock.com. REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence ...

The trial’s primary efficacy goal is to measure the rate of growth of atrophic lesions in the retina. Credit: SaiArLawKa2 / Shutterstock.com. Belite Bio has concluded the final participant visit in ...

Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of ...

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

These readouts will help Regeneron structure the confirmatory trials for the two allergy combination therapies.

On this episode, the healthcare editorial team unpicks several key trials and trends from this year’s event, held from 29 August to 1 September in Madrid. Data at ESC is from studies evaluating ...

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

AstraZeneca's Tagrisso, in combination with pemetrexed and platinum-based chemotherapy, has shown a significant improvement ...

Takeda’s readout comes from two pivotal Phase III trials of its OX2R, with Alkermes’ data coming from a Phase II trial in NT1 ...

RealTime eClinical Solutions has rolled out the TrialAlign platform that aims to refine the performance analytics for ...

Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC trials.

In the real-world trial, Novo Nordisk's Wegovy showed a significant reduction in CV events compared to Eli Lilly’s Zepbound.